Promising Targets for Anti-Hepatitis C Virus Agents

被引:8
|
作者
Yoshida, T. [1 ]
Kondoh, M. [1 ]
Yagi, K. [1 ]
机构
[1] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Biofunct Mol Chem, Suita, Osaka 5650871, Japan
关键词
Hepatitis C virus; CD81; claudin-1; NS3; helicase; cyclophilin; miRNA122; INTERNAL RIBOSOMAL ENTRY; PLACEBO-CONTROLLED TRIAL; P7; ION-CHANNEL; HELICASE ACTIVITY; BINDING-PROTEIN; RNA HELICASE; ANTIVIRAL ACTIVITY; INITIAL TREATMENT; POTENT INHIBITOR; NS4A ANTAGONIST;
D O I
10.2174/092986711795029672
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hepatitis C virus (HCV) infection is a serious global health problem, with 3-4 million new cases reported each year. Chronic HCV infection places 170 million people at risk of developing liver cirrhosis and hepatocellular carcinoma. However, difficulties in preparing HCV particles in vitro have delayed development of effective anti-HCV therapies. In 2005, Wakita et al. developed an in vitro method to prepare HCV particles, thereby enabling researchers to better understand the mechanism of HCV infection. Other recent advances include development of a virus-free system for evaluating HCV replication and the identification of HCV receptors, such as claudin-1 and occludin, that may serve as targets for anti-HCV drugs. In this review, we discuss recent findings in HCV infection research, including discovery of new potential targets for anti-HCV therapy.
引用
收藏
页码:1239 / 1244
页数:6
相关论文
共 50 条
  • [1] Promising alkaloids and flavonoids compounds as anti-hepatitis c virus agents: a review
    Rizaldi, Gusti
    Hafid, Achmad Fuad
    Wahyuni, Tutik Sri
    JOURNAL OF PUBLIC HEALTH IN AFRICA, 2023, 14
  • [2] Serine protease inhibitors as anti-hepatitis C virus agents
    Reiser, Markus
    Timm, Joerg
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2009, 7 (05) : 537 - 547
  • [3] Promising Anti-Hepatitis C Virus Compounds from Natural Resources
    Wahyuni, Tutik Sri
    Utsubo, Chie Aoki
    Hotta, Hak
    NATURAL PRODUCT COMMUNICATIONS, 2016, 11 (08) : 1193 - 1200
  • [4] Novel symmetrical phenylenediamines as potential anti-hepatitis C virus agents
    Bassetto, Marcella
    Ferla, Salvatore
    Leyssen, Pieter
    Neyts, Johan
    Yerukhimovich, Mark M.
    Frick, David N.
    O'Donnell, Rachel
    Brancale, Andrea
    ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 2015, 24 (5-6): : 155 - 160
  • [5] Cellular models for the screening and development of anti-hepatitis C virus agents
    Gondeau, Claire
    Pichard-Garcia, Lydiane
    Maurel, Patrick
    PHARMACOLOGY & THERAPEUTICS, 2009, 124 (01) : 1 - 22
  • [6] Fused heterocyclic amido compounds as anti-hepatitis C virus agents
    Aoyama, Hiroshi
    Sugita, Kazuyuki
    Nakamura, Masahiko
    Aoyama, Atsushi
    Salim, Mohammed T. A.
    Okamoto, Mika
    Baba, Masanori
    Hashimoto, Yuichi
    BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (08) : 2675 - 2687
  • [7] Research development of anti-hepatitis B virus agents
    Chen, Zhi-qiang
    Dong, Jun-xing
    Zhongguo Yaoxue Zazhi/Chinese Pharmaceutical Journal, 2000, 35 (07): : 435 - 437
  • [8] Design and Development of Anti-Hepatitis B Virus Agents
    Kaushik, S.
    Gupta, S. P.
    Sharma, P. K.
    CURRENT MEDICINAL CHEMISTRY, 2010, 17 (29) : 3377 - 3392
  • [9] Anti-hepatitis C virus drug simeprevir: a promising antimicrobial agent against MRSA
    Yimin Li
    Pengfei She
    Lanlan Xu
    Yaqian Liu
    Shasha Liu
    Zehao Li
    Yifan Yang
    Linhui Li
    Zubair Hussain
    Yong Wu
    Applied Microbiology and Biotechnology, 2022, 106 : 2689 - 2702
  • [10] The evaluation of the inhibitory effect of oral anti-hepatitis C virus agents on carcinogenesis
    Mawatari, Seiichi
    Moriuchi, Akihiro
    Tashima, Shuzo
    Kasai, Ai
    Ijuin, Sho
    Tabu, Kazuaki
    Oda, Kohei
    Ido, Akio
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E741 - E741